Drug
Betrixaban
Betrixaban: highest development phase Phase 1, developed by United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Betrixaban NCT01765868 | Phase 1 | Healthy Subjects |
| Betrixaban NCT00999336 | Phase 1 | Renal Impairment |
Latest
No recent events.
Follow Betrixaban on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.